BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 24, 2012
View Archived Issues
Study reveals new therapeutic use for phosphodiesterase 5 inhibitors
Read More
Revalesio set to launch new trial of nebulized asthma combination therapy
Read More
SK Biopharmaceuticals begin U.S. phase II trial of SKL-11197
Read More
HER2 gene imaging analysis system receives FDA clearance
Read More
New hepatocyte growth factor receptor inhibitor advances to clinic
Read More
Daiichi Sankyo reviews pipeline progress
Read More
Japanese researchers design novel agents for neuropathic pain
Read More
Bristol-Myers Squibb presents new anticancer agents
Read More
Roche offers overview of 2011
Read More
Novel cannabinoid receptor agonists disclosed by Astellas Pharma
Read More
Corning presents novel compounds for GPR35 receptor-related disorders
Read More
Spanish scientists patent new protein kinase inhibitors
Read More
First visceral leishmaniasis vaccine enters clinical testing
Read More
Novel agents for pain prepared by Nutek Pharma
Read More
New system allows creation and screening of macrocyclic N-methylated peptide libraries
Read More
PDUFA date set for Impax Pharmaceuticals' IPX-066 NDA
Read More
VX-222 combination therapy shows promise in hepatitis C
Read More
New therapeutic target identified for hepatitis C
Read More
FDA committee votes on aclidinium bromide NDA
Read More
Can-Fite BioPharma product obtains FDA orphan drug status
Read More
Cedars-Sinai receives grant for Alzheimer's research
Read More
ULURU's Altrazeal obtains approval in Australia
Read More
Omeros unlocks new class A orphan GPCRs
Read More
EMA grants new marketing approval for dry powder inhaler
Read More
EMA accepts Genzyme's teriflunomide MAA
Read More
Dosing begins in phase I Vasomera trial
Read More